Yintao Li

7PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 27, 2026
Real-world comparison of chemoimmunotherapy and chemotherapy alone in elderly patients (≥75 years) with extensive-stage small cell lung Cancer.

|Jun 01, 2026
Sintilimab plus concurrent chemoradiotherapy for treatment of locally advanced small cell lung cancer (SINCE-01): a phase II clinical trial.

|Nov 27, 2025
Efficacy of Almonertinib Versus Osimertinib as the First-Line Treatment for Non-Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study.

Xiujing Yao, Ruyue Li, Xue Dong

|Apr 18, 2025
Nomogram based on computed tomography radiomics features and clinicopathological factors to predict the prognosis of patients with non-small cell lung cancer receiving immune checkpoint inhibitor rechallenge.

Junfeng Zhao, Ying Li, Ruyue Li

|Mar 14, 2025
Efficacy and safety of immunotherapy plus chemotherapy in advanced or metastatic pulmonary large-cell neuroendocrine carcinoma.

Ruyue Li, Huanle Zhang, Ying Li

|Feb 17, 2025
Adjuvant treatment after neoadjuvant chemoradiotherapy and surgery in patients with esophageal squamous cell carcinoma: a real-world study.

Yuxin Geng, Junfeng Zhao, Ying Li

Pageof 2

Frequent Collaborators

2 joint publications

Junfeng Zhao

2 joint publications

Ying Li

1 joint publications

Ruyue Li

1 joint publications

Huanle Zhang